exited at 25 earlier in april, time to get back in. Stellar results, will help FPH also as steveaussie correctly pointed out initially. But next week will be tough both on NYSE and ASX. Now the question is, what offers better buy medium to long term reward RMD or FPH? I am very worried about next US GDP quarter. FPH could be a better buy with the June29 expectation in mind. RMD Q4 guidance also compelling.
Ann: ResMed Announces Results for the Third Quarter of FY2020, page-9
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.56 |
Change
0.520(1.44%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $36.32 | $36.74 | $36.27 | $24.77M | 684.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 50 | $36.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.57 | 573 | 15 |
View Market Depth
| Last trade - 14.25pm 18/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |